In ANI's New Day trial, patients were randomized to an induction phase to receive either a single Iluvien injection or a series of five monthly injections of aflibercept, followed by supplemental ...

ANI Pharmaceuticals (ANIP) stock drops as its Iluvien implant fails in a clinical trial versus Eylea marketed by Regeneron (REGN) and Sanofi (SNY). Read more here.

Trial evaluated number of supplemental injections needed for the treatment of DME for patients on ILUVIEN versus the ...